下記論文が「Blood Advances」誌に採択されました。
Novel anti-myeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
T. Harada, H. Ohguchi, A. Oda, M. Nakao, J. Teramachi, M. Hiasa, R. Sumitani, M. Oura, K. Sogabe, T. Maruhashi, M. Takahashi, S. Fujii, S. Nakamura, H. Miki, K. Kagawa, S. Ozaki, S. Sano, T. Hideshima, and M. Abe,
Blood Advances, in press.
Read Blood Advances at
https://ashpublications.org/bloodadvances/first-edition
